NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹7.18 Cr | ₹-1.46 Cr | ₹1.70 Cr | ₹-0.39 Cr | ₹-0.70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NGL FINECHEM ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹7.18 Cr |
Mar2022 | ₹-1.46 Cr |
Mar2021 | ₹1.70 Cr |
Mar2020 | ₹-0.39 Cr |
Mar2019 | ₹-0.70 Cr |
How is Net Cash Inflow / Outflow of NGL FINECHEM Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹7.18 Cr | Positive | |
Mar2022 | ₹-1.46 Cr | Negative | |
Mar2021 | ₹1.70 Cr | Positive | |
Mar2020 | ₹-0.39 Cr | Negative | |
Mar2019 | ₹-0.70 Cr | - |
Compare Net Cash Inflow / Outflow of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,437.4 Cr | -12% | 8.5% | 53.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,071.0 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,300.0 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,202.0 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,035.0 Cr | -3.7% | -1.4% | 26% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -12% |
8.5% |
53.5% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses